Mallinckrodt News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.01.18	Mallinckrodt Will Sell RECOTHROM® And PREVELEAK® To Baxter (PR Newswire)
05.01.18	EARS Down But Not Out, Major Event Awaits AMRN In Q3, Exciting Time For TTOO (RTTNews)
04.01.18	Mallinckrodt Completes Stannsoporfin New Drug Application Filing (PR Newswire)
02.01.18	Wolf Popper LLP Investigates the Proposed Acquisition of Sucampo Pharmaceuticals, Inc. by Mallinckrodt plc (PR Newswire)
26.12.17	MÄRKTE USA/Kleine Verluste - Apple drückt Techsektor (Dow Jones)
26.12.17	Mallinckrodt Pulls Back Off Best Levels But Remains Positive (RTTNews)
26.12.17	MÄRKTE USA/Apple verdirbt Stimmung für Technologiewerte (Dow Jones)
26.12.17	MÄRKTE USA/Impulsarmes Geschäft an Wall Street - Apple schwach (Dow Jones)
26.12.17	MÄRKTE USA/Verhaltener Start an der Wall Street - Apple schwach (Dow Jones)
26.12.17	Mallinckrodt To Buy Sucampo Pharma In $1.2 Bln Deal - Quick Facts (RTTNews)
26.12.17	Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion (PR Newswire)
19.12.17	Mallinckrodt plc to Report Fourth Quarter and Full-Year 2017 Earnings Results on Feb. 27, 2018 (PR Newswire)
13.12.17	MÄRKTE USA/Wall Street am Tag der Fed mit neuen Rekordhochs (Dow Jones)
13.12.17	MÄRKTE USA/Wall Street am Tag der Fed knapp im Plus (Dow Jones)
13.12.17	MÄRKTE USA/Wall Street am Tag der Fed knapp im Plus gesehen (Dow Jones)
11.12.17	Mallinckrodt Completes Acquisition of Ocera Therapeutics and OCR-002, Its Proprietary Therapy in Development for Treatment of Hepatic Encephalopathy (PR Newswire)
04.12.17	Mallinckrodt plc Presents Health Economic Data on Management of Infantile Spasms at American Epilepsy Society Annual Meeting (PR Newswire)
22.11.17	Mallinckrodt In The Red Following Downgrade By Oppenheimer (RTTNews)
20.11.17	Chicago Rivet & Machine Co. Declares Dividend (PR Newswire)
16.11.17	Mallinckrodt plc Presents Health Economic Data on OFIRMEV® (acetaminophen) Injection at ASRA 16th Annual Pain Medicine Meeting (PR Newswire)
14.11.17	Mallinckrodt To Present At The BMO Prescriptions for Success Healthcare Conference (PR Newswire)
07.11.17	Mallinckrodt plc Reports Earnings Results for Third Quarter of Fiscal 2017 (PR Newswire)
02.11.17	Mallinckrodt To Acquire Ocera Therapeutics And OCR-002, Its Proprietary Therapy In Development For Treatment Of Hepatic Encephalopathy (PR Newswire)
27.10.17	Patient Survey Studies Find Multiple Sclerosis Relapse is Underreported; Approximately Half of Patients Do Not Always Engage with Healthcare Practitioners During Relapse (PR Newswire)
26.10.17	Mallinckrodt plc Presents Multiple Sclerosis (MS) Relapse Data at 7th Joint ECTRIMS-ACTRIMS Meeting (MSParis2017) (PR Newswire)
25.10.17	Hitachi Capital America Vendor Services and Panasas Launch New Financing Program (PR Newswire)
23.10.17	Mallinckrodt Presents Health Economic Data Related to Hepatorenal Syndrome at The Liver Meeting® 2017, the Annual Meeting of the American Association for the Study of Liver Diseases (PR Newswire)
18.10.17	Mallinckrodt To Present At The Stifel 2017 Healthcare Conference (PR Newswire)
16.10.17	Mallinckrodt Opens Specialty Brands Office In New Jersey, Announces $100,000 Donation To Princeton University Program For High Achieving, Low-Income High School Students (PR Newswire)
10.10.17	Mallinckrodt plc to Report Earnings Results for Third Quarter of Fiscal 2017 (PR Newswire)
09.10.17	Mallinckrodt Will Conduct Phase 4 Trial of H.P. Acthar® Gel (Repository Corticotropin Injection) for Symptomatic Sarcoidosis (PR Newswire)
04.10.17	Mallinckrodt Details Development Pipeline Highlights - Quick Facts (RTTNews)
04.10.17	Mallinckrodt plc Discusses Pipeline Transformation, Company Outlook at Investor Briefing (PR Newswire)
02.10.17	Mallinckrodt Licenses Inhaled Xenon Gas Therapy Development Product (PR Newswire)
26.09.17	Novo Nordisk Teams Up with HITLAB to Challenge Innovators to Develop Voice-Activated Technology for Diabetes Care with $75,000 in Prizes (PR Newswire)
25.09.17	Mallinckrodt Completes Acquisition of InfaCare Pharmaceutical Corporation and Stannsoporfin, its Proprietary Therapy in Late-Stage Development for Newborns at Risk for Severe Jaundice (PR Newswire)
25.09.17	Cars.com to Present at Barrington Research and B. Riley Conferences (PR Newswire)
22.09.17	Mallinckrodt Advocates for Comprehensive, Multi-Prong Action Plan to Fight Opioid Abuse and Misuse in the United States (PR Newswire)
21.09.17	Patricia Kunz Howard, PhD, RN, CEN, CPEN, NE-BC, TCRN, FAEN, FAAN, Named 2018 President-elect of Emergency Nurses Association (PR Newswire)
20.09.17	Mallinckrodt Announces Election Of David Norton To Its Board Of Directors (PR Newswire)
18.09.17	Breakfast Technical Briefing on Generic Drugs Stocks -- Mallinckrodt, Horizon Pharma, Mylan, and Neurocrine Biosciences (PR Newswire)
13.09.17	Mallinckrodt Firmly In The Red On Downgrade By Mizuho Securities (RTTNews)
17.08.17	Leading Biotech Companies Receiving Orphan Drug Designation in 2017 (PR Newswire)
17.08.17	Leading Biotech Companies Receiving Orphan Drug Designation in 2017 (PR Newswire)
15.08.17	Mallinckrodt To Present At Morgan Stanley 15th Annual Global Healthcare Conference (PR Newswire)
08.08.17	Mallinckrodt Q2 Profit Down; Backs 2017 Adj. EPS View (RTTNews)
08.08.17	Mallinckrodt plc Reports Earnings Results for Second Quarter of Fiscal 2017 (PR Newswire)
07.08.17	Mallinckrodt To Present At Wells Fargo Securities 2017 Healthcare Conference (PR Newswire)
07.08.17	AQB Reaps A Bounty, CLSN Ends Dual Listing, MNK Opens Wallet, OMER On Watch (RTTNews)
04.08.17	Mallinckrodt To Buy InfaCare - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Mallinckrodt PLC

Aktien Top/Flop

Meistgelesene Nachrichten